P11838 (CARP_CRYPA) Cryphonectria parasitica (Chestnut blight fungus) (Endothia parasitica)
Endothiapepsin UniProtKBInterProInteractive Modelling
419 aa; Sequence (Fasta) ;
1 identical sequence: Cryphonectria parasitica EP155: A0A9P4XSY9
It is possible new templates exist for this target since these models were created.
Available Structures
804 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Endothiapepsin complex with H189 |
Heteromer P01017; | 2×SO4; | ||||
| Assess | ||||||
| THE ACTIVE SITE OF ASPARTIC PROTEINASES |
Heteromer P01017; | |||||
| Assess | ||||||
| THE ACTIVE SITE OF ASPARTIC PROTEINASES |
Heteromer P01016; | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 39 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 26, … | monomer | |||||
| Assess | ||||||
| ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN | monomer | 1×SER; 1×THR; 1×GOL; 5×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R8S; 1×DMS; 4×GOL; 2×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 29, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 33, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry H11, DMSO-free | monomer | 2×REG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 05 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 27, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 25, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 43 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 25 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry C04, DMSO-free | monomer | 1×R8S; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU5-4 | monomer | 2×GOL; 2×ZSA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 45, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 36, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R9G; 2×DMS; 2×GOL; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 17 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 23, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 12, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 58 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 41 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 14 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 49 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R8Y; 1×DMS; 2×GOL; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 37 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×AES; 2×DMS; 3×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 37, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 51, … | monomer | |||||
| Assess | ||||||
| Cocktail experiment C: fragments 103 and 171 in complex with Endothiapepsin | monomer | 2×DMS; 2×GOL; 1×ACT; 1×46P; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 32 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 47 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 30 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RQD; 4×DMS; 3×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 54 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RAY; 3×DMS; 3×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU290-1 | monomer | 2×ZSM; | ||||
| Assess | ||||||
| Endothiapepsin complex with CP-80,794 | monomer | 1×2ZS; 2×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 5×GOL; 2×ACT; 1×DMS; 1×RDM; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| Endothiapepsin in its apo form | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 03, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 28, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 09, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 23 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU5-2 | monomer | 7×ZS1; 2×DMS; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 40 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 59 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 04 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a gem-diol inhibitor. | monomer | 1×0QS; 4×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RB7; 2×DMS; 4×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R8V; 3×GOL; 2×DMS; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 6×GOL; 1×ACT; 1×PG4; 1×NA; 2×R9J; 4×DMS; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 2×RE7; 3×DMS; 4×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU58-1 | monomer | 1×GOL; 2×EDO; 1×ZSD; | ||||
| Assess | ||||||
| Endothiapepsin complexed with H256 | monomer | 2×SO4; | ||||
| Assess | ||||||
| Endothiapepsin complex with PD-130,328 | monomer | 1×0EM; 2×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 06, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 22, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 10, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 38, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 30, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 05, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry E06, DMSO-free | monomer | 1×R9V; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 50, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 17, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 06 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 36 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R97; 3×DMS; 1×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 15 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 46 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 04, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry G08, DMSO-free | monomer | 1×RDJ; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry H03, DMSO-free | monomer | 1×RDY; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RDY; 2×DMS; 5×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 34 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU58-3 | monomer | 1×ZSJ; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry F03, DMSO-free | monomer | 1×RAY; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 07, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry G03, DMSO-free | monomer | 2×RD4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 44 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B97 | monomer | 5×GOL; 2×ACT; 4×DMS; 1×LNR; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RBG; 3×DMS; 5×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 35 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 08 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 177 and a derivative thereof | monomer | 2×DMS; 4×GOL; 2×ACT; 1×7B2; 1×7B4; 1×TFA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 57 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 3×GOL; 1×ACT; 1×PG4; 1×R9V; 3×DMS; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 53 | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 29 | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 07 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 48 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry D10, DMSO-free | monomer | 1×R9J; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 58, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 24, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 14, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 46, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 31, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 41, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry B03, DMSO-free | monomer | 2×T9G; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 42, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 42 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 22 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 2×RDV; 1×DMS; 3×GOL; 1×ACT; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RCV; 1×DMS; 4×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 18 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 21 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R8P; 3×DMS; 5×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RDJ; 2×DMS; 4×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 19 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 50 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 33 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU58-2 | monomer | 1×ZSG; 2×EDO; 2×GOL; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry E07, DMSO-free | monomer | 1×R9Y; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 15, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 52, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 19, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry H02, DMSO-free | monomer | 2×RDV; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Fragment 333 at a concentration of 50mM in complex with Endothiapepsin | monomer | 3×GOL; 1×ACT; 1×5GL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R9Y; 1×DMS; 3×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×SYG; 3×DMS; 3×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 3×RE4; 1×DMS; 2×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 51 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 13 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Five Atomic Resolution Structures of Endothiapepsin Inhibitor Complexes; implications for the Aspar… | monomer | 1×0GM; 2×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry G02, DMSO-free | monomer | 2×RCV; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 47, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 291 | monomer | 1×GOL; 2×ACT; 1×DMS; 2×F91; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 01 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry D11, DMSO-free | monomer | 1×R9M; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 59, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a methoxylated derivative of fragment 177 | monomer | 2×ACT; 2×GOL; 4×DMS; 2×7B3; 1×TFA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry D04, DMSO-free | monomer | 2×RQD; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 60, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 53, … | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 211 | monomer | 1×78B; 1×DMS; 4×GOL; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 32, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 43, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry C11, DMSO-free | monomer | 1×R8Y; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 49, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 61, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry F08, DMSO-free | monomer | 2×RBJ; 1×ACT; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 11, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Cocktail experiment G: fragments 216 and 338 at 90 mM concentration in complex with Endothiapepsin | monomer | 1×483; 1×8NE; 1×GOL; 5×DMS; 1×ACT; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 3×RD4; 2×DMS; 3×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 10 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 24 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R8A; 1×DMS; 1×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 52 | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 34, … | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 54, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 12 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 45 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry E11, DMSO-free | monomer | 1×RA7; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 01, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B29 | monomer | 5×GOL; 3×ACT; 5×DMS; 1×0A9; | ||||
| Assess | ||||||
| Endothiapepsin in complex with 017 | monomer | 1×GOL; 1×KHW; 1×DMS; 1×KHZ; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 266 | monomer | 1×GOL; 1×ACT; 1×46L; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 3×GOL; 1×ACT; 1×PG4; 1×NA; 1×R9M; 4×DMS; | ||||
| Assess | ||||||
| Fragment screening hit III bound to endothiapepsin | monomer | 1×GOL; 1×TUU; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 16 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Pyrrolidine fragment 5b bound to endothiapepsin | monomer | 1×GOL; 1×TVO; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU5-1 | monomer | 4×DMS; 1×ZRY; 1×GOL; | ||||
| Assess | ||||||
| Fragment screening hit I bound to endothiapepsin | monomer | 1×TT6; 1×GOL; | ||||
| Assess | ||||||
| Atomic Resolution Structure of Endothiapepsin in Complex with a Hydroxyethylene Transition State An… | monomer | 1×GOL; 4×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry G09, DMSO-free | monomer | 1×RDM; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 40, … | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 323 | monomer | 1×ACT; 2×GOL; 2×PGE; 1×47H; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Structure resulting from an endothiapepsin crystal soaked with a dimeric derivative of fragment 177 | monomer | 2×DMS; 2×TFA; 2×GOL; 2×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 31 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 20 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 268 | monomer | 2×GOL; 1×ACT; 1×47T; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 55, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 02, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 41 | monomer | 1×ACT; 2×GOL; 2×EDO; 1×F41; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 38 | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RA7; 3×DMS; 2×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| Endothiapepsin in complex with thiophen-based inhibitor SAP114 | monomer | 1×1VT; 1×GOL; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-347283 complex | monomer | 3×GOL; 1×ACT; 3×DMS; 3×D9V; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 21, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 285 | monomer | 1×463; 1×GOL; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 28 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 55 | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 306 | monomer | 2×GOL; 1×F06; 1×ACT; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 216 | monomer | 1×FBF; 2×GOL; 1×EDO; 1×ACT; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 18, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×R9S; 2×DMS; 3×GOL; 1×ACT; 1×PG4; 1×NA; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 56 | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fluorinated primary amine fragment | monomer | 2×ACT; 1×PGE; 3×DMS; 1×PG4; 1×6LZ; 1×GOL; | ||||
| Assess | ||||||
| Cocktail experiment E: fragments 52, 58, and 63 at 90 mM concentration in complex with Endothiapeps… | monomer | 1×F63; 4×DMS; 1×GOL; | ||||
| Assess | ||||||
| Cocktail experiment A: fragments 63, 267, and 291 in complex with Endothiapepsin | monomer | 6×DMS; 1×GOL; 1×47V; 2×F91; 1×F63; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 16, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Pyrrolidine fragment 10d bound to endothiapepsin | monomer | 1×GOL; 2×TWX; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound 046 | monomer | 1×KCE; 1×GOL; 2×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 27 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Fragment screening hit IV bound to endothiapepsin | monomer | 1×GOL; 2×TV6; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 66 | monomer | 1×GOL; 1×5HQ; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 205 | monomer | 8×GOL; 2×ACT; 2×TP5; 1×DMS; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 57, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 260 | monomer | 2×ACT; 4×DMS; 1×PEG; 1×PG4; 1×47L; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B39 | monomer | 6×DMS; 5×GOL; 4×ACT; 1×011; 1×EDO; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 181 | monomer | 2×ACT; 6×GOL; 1×DMS; 1×45O; 1×EDO; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 35, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 109 | monomer | 1×F02; 3×GOL; 2×DMS; 1×PEG; 2×ACT; 1×PGE; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU290-2 | monomer | 1×DMS; 2×GOL; 3×ZSS; 1×BR; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with hydrazide | monomer | 2×ACT; 1×GOL; 1×601; 1×PG4; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 13, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 1×RBJ; 1×DMS; 4×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 26 | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry H05, DMSO-free | monomer | 4×RE4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry A07, DMSO-free | monomer | 1×R8A; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 39, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 56, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin in complex with fragment F2X-Entry F04, DMSO-free | monomer | 1×RB7; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 162 | monomer | 1×479; 1×ACT; 2×GOL; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 267 | monomer | 3×GOL; 1×ACT; 1×47V; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG056 complex | monomer | 3×GOL; 1×ACT; 1×D5V; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B91 | monomer | 6×DMS; 8×GOL; 4×ACT; 1×IMI; 1×EDO; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 75 | monomer | 1×GOL; 1×PEG; 1×ACT; 1×EDO; 1×45M; 3×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Pyrrolidine fragment 10b bound to endothiapepsin | monomer | 1×GOL; 2×TW0; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU5-3 | monomer | 2×GOL; 2×ZS7; 4×DMS; | ||||
| Assess | ||||||
| Cocktail experiment D: fragments 308 and 333 at 50mM concentration | monomer | 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 44, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 236 | monomer | 1×4AV; 2×DMS; 5×GOL; 2×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 09 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 48, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 02 | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with saquinavir | monomer | 1×ROC; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 338 | monomer | 3×GOL; 1×483; 1×ACT; 1×DMS; | ||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 03 | monomer | 3×GOL; 2×ACT; 1×PGE; 1×PG4; 1×NA; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 189 | monomer | 2×ACT; 7×GOL; 1×45X; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin changed state model for fragment F2X-Entry Libra… | monomer | 2×DMS; 2×REG; 3×GOL; 1×ACT; 1×PG4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 311 | monomer | 5×GOL; 1×5HJ; 1×ACT; 1×PGE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin structure obtained at 100K with fragment AC39729 bound | monomer | 1×U1Q; 23×DMS; 1×PEG; 1×1PE; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 164 | monomer | 1×GOL; 1×ACT; 1×46Y; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 261 | monomer | 2×GOL; 3×47P; 1×DMS; 2×ACT; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG080 complex | monomer | 3×GOL; 1×D6D; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 158 | monomer | 2×GOL; 1×ACT; 2×47K; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 333 | monomer | 3×GOL; 2×ACT; 1×DMS; 1×EDO; 1×5GL; | ||||
| Assess | ||||||
| 100K endothiapepsin structure obtained in presence of 40 mM DMSO | monomer | 4×1PE; 8×DMS; 2×PEG; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 224 | monomer | 2×4AQ; 1×DMS; 5×GOL; 2×ACT; 1×1PE; 1×PEG; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B50 | monomer | 5×GOL; 2×ACT; 4×DMS; 1×GLY; 1×PRO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a derivative of fragment 177 | monomer | 1×7B2; 4×GOL; 1×ACT; 2×DMS; 2×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 171 | monomer | 2×46P; 4×GOL; 1×DMS; 1×ACT; | ||||
| Assess | ||||||
| Fragment screening hit II bound to endothiapepsin | monomer | 1×GOL; 1×TU5; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×FBF; 2×GOL; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 5 | monomer | 2×GOL; 1×ACT; 1×F05; 1×DMS; 1×PGE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with 100mM acylhydrazone inhibitor | monomer | 1×DMS; 3×1TZ; 2×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG203 complex | monomer | 3×GOL; 1×ACT; 2×D8J; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B51 | monomer | 4×GOL; 2×ACT; 4×DMS; 1×CFF; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 227 | monomer | 4×GOL; 1×4AY; 1×BR; 1×DMS; 1×EDO; 1×PG4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with an inhibitor based on the Gewald reaction | monomer | 1×GOL; 1×4SH; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 286 | monomer | 2×GOL; 1×ACT; 1×47G; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-347144 complex | monomer | 2×DMS; 2×D97; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 328 | monomer | 2×47Y; 2×GOL; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Auto-refined data of Endothiapepsin for ground state model 20, … | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 337 | monomer | 1×487; 2×GOL; 1×ACT; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-347290a complex | monomer | 2×GOL; 3×ACT; 3×DMS; 1×D9Y; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 240 | monomer | 1×4AS; 2×GOL; 1×EDO; 2×ACT; 1×PEG; 1×PGE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Cocktail experiment B: fragments 224 and 236 at 50mM concentration | monomer | 1×GOL; 1×4AV; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-346985 complex | monomer | 2×GOL; 2×ACT; 3×DMS; 1×DDV; 1×PEG; 2×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with an inhibitor based on the Gewald reaction | monomer | 1×RB4; 2×DMS; 1×GOL; 1×ACT; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 131 | monomer | 1×GOL; 1×ACT; 1×46R; 1×PGE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 114 | monomer | 1×PEG; 1×EDO; 2×DMS; 3×GOL; 2×46X; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B30 | monomer | 5×GOL; 5×ACT; 4×DMS; 1×HIC; | ||||
| Assess | ||||||
| Endothiapepsin in complex with 20mM acylhydrazone inhibitor | monomer | 2×1TZ; 5×DMS; 4×GOL; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 81 | monomer | 1×47S; 3×GOL; 1×ACT; 1×EDO; 1×PGE; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with an azepin derivative | monomer | 1×NC8; 1×NC9; 1×Z82; 1×GOL; 1×SO4; 2×DMS; 1×CL; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 31 | monomer | 1×51V; 2×GOL; 1×ACT; 1×1PE; 1×PEG; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG134 complex | monomer | 6×GOL; 2×DMS; 1×D6V; 2×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| PanDDA analysis group deposition -- Endothiapepsin ground state model 11 | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 273 | monomer | 1×GOL; 1×45V; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B42 | monomer | 5×GOL; 2×ACT; 4×DMS; 1×DCL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin complexed with Phe-reduced-Tyr peptide. | monomer | 3×SO4; 6×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a hydrazide derivative | monomer | 2×7SP; 2×PGE; 1×GOL; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a pyrrolidine based inhibitor | monomer | 1×DMS; 1×S47; 2×GOL; 1×1PE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with biacylhydrazone | monomer | 1×DMS; 3×GOL; 1×ACT; 1×61P; 1×EDO; 1×PG4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with chiral brominated primary amine fragment | monomer | 1×6LY; 1×PG4; 2×ACT; 1×GOL; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin PD135,040 complex | monomer | 1×0QS; 2×SO4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with thiophen-based inhibitor SAP128 | monomer | 2×DMS; 1×1VS; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with ritonavir | monomer | 1×RIT; 1×DMS; 1×1PE; 1×PGE; 1×GOL; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×41L; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with ligand TL00150 in 10% DMSO at 100K | monomer | 1×PG5; 6×DMS; 1×U1H; | ||||
| Assess | ||||||
| Endothiapepsin in 20% DMSO at 100 K | monomer | 6×DMS; 1×PG5; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 203 | monomer | 3×ACT; 3×GOL; 1×EDO; 3×DMS; 1×5GC; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin structure obtained at 100K with fragment JFD03909 bound | monomer | 1×PHN; 25×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound FU66-1 | monomer | 1×GOL; 1×ZSY; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 78 | monomer | 2×DMS; 3×GOL; 1×EDO; 1×78B; 1×ACT; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F90; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT14-350193 complex | monomer | 3×DMS; 2×GOL; 2×ACT; 2×D9S; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 112 | monomer | 1×EDO; 2×GOL; 2×46O; 2×ACT; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with Gewald reaction-derived inhibitor (5) | monomer | 3×ACT; 2×PG4; 1×PG6; 2×PEG; 1×IXZ; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in 5% DMSO at 100 K | monomer | 6×DMS; 1×PG5; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in 10% DMSO at 100 K | monomer | 6×DMS; 1×PG5; | ||||
| Assess | ||||||
| Endothiapepsin apo at 100K | monomer | 1×PG5; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin | monomer | 2×ACT; 1×GOL; 2×DMS; 1×DD4; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG166 complex | monomer | 3×GOL; 1×DMS; 1×D8A; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 255 | monomer | 3×GOL; 1×ACT; 1×PGE; 1×F5N; 1×PG4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 207 | monomer | 6×GOL; 3×ACT; 6×DMS; 1×46J; 2×46H; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin structure obtained at 100K with fragment BTB09871 bound | monomer | 1×U1E; 27×DMS; 1×PEG; 2×CL; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F7L; | ||||
| Assess | ||||||
| Endothiapepsin in complex with an inhibitor based on the Gewald reaction | monomer | 1×RB9; 1×DMS; 1×GOL; 1×PG4; 1×1PE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment B53 | monomer | 5×GOL; 2×ACT; 3×DMS; 1×GGB; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 274 | monomer | 2×GOL; 1×ACT; 2×DMS; 1×489; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG164 complex | monomer | 3×GOL; 1×ACT; 1×D74; | ||||
| Assess | ||||||
| Endothiapepsin in complex with Gewald reaction-derived inhibitor (8) | monomer | 1×IXV; 1×PEG; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 206 | monomer | 3×ACT; 3×DMS; 8×GOL; 1×EDO; 1×47M; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 278 | monomer | 3×GOL; 1×ACT; 1×EDO; 3×DMS; 1×5GJ; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 125 | monomer | 3×DMS; 2×EDO; 3×GOL; 1×PEG; 1×ACT; 1×SO4; 2×46W; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 290 | monomer | 1×ACT; 2×GOL; 2×DMS; 1×F90; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG270 complex | monomer | 3×GOL; 1×D8M; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 209 | monomer | 1×ACT; 3×GOL; 1×5HS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 272 | monomer | 1×47U; 1×GOL; 1×ACT; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 330 | monomer | 1×5G1; 1×GOL; 1×ACT; 1×PGE; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG081 complex | monomer | 3×GOL; 1×ACT; 1×D6S; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 42 | monomer | 2×GOL; 1×46T; 1×EDO; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 73 | monomer | 3×GOL; 2×ACT; 1×EDO; 1×47R; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F02; 1×GOL; 2×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 321 | monomer | 1×45N; 2×ACT; 2×GOL; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 34 | monomer | 1×GOL; 1×5HL; 1×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 63 | monomer | 1×ACT; 2×GOL; 1×F63; 1×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG175 complex | monomer | 3×GOL; 1×ACT; 1×D8D; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG075 complex | monomer | 4×GOL; 2×DMS; 1×D6A; | ||||
| Assess | ||||||
| Endothiapepsin in complex with benzamidine | monomer | 3×BEN; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 231 | monomer | 2×ACT; 1×GOL; 2×DMS; 1×PG4; 1×5GQ; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 48 | monomer | 2×GOL; 1×5HO; 1×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-346976 complex | monomer | 4×ACT; 2×DMS; 1×DD7; 1×PEG; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG062 complex | monomer | 3×GOL; 3×DMS; 1×D5Y; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 17 | monomer | 2×GOL; 2×46S; | ||||
| Assess | ||||||
| X-ray crystal structure of endothiapepsin complexed with compound 1 | monomer | 3×GOL; 2×ACT; 1×V15; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 103 | monomer | 3×GOL; 1×PGE; 1×45Y; 1×PEG; 2×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-347151 complex | monomer | 1×DMS; 1×GOL; 1×D9M; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a gem-diol inhibitor. | monomer | 1×0QS; 1×SO4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin with Ligand VSK-B24 | monomer | 1×VSK; 1×DMS; 1×PGE; 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 35 | monomer | 1×GOL; 2×46Q; 1×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 4 | monomer | 1×GOL; 3×EDO; 1×PGE; 1×45L; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED… | monomer | 3×SO4; | ||||
| Assess | ||||||
| A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITI… | monomer | 1×2ZS; 3×SO4; | ||||
| Assess | ||||||
| A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITI… | monomer | 3×SO4; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 52 | monomer | 1×GOL; 1×EDO; 1×47A; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 56 | monomer | 3×EDO; 1×ACT; 1×GOL; 1×47E; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-NAT17-347147 complex | monomer | 1×GOL; 2×EDO; 1×DMS; 2×D9D; 1×ACT; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 54 | monomer | 1×GOL; 2×47B; 1×EDO; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG274 complex | monomer | 3×GOL; 1×ACT; 1×D8P; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 58 | monomer | 1×GOL; 3×DMS; 1×EDO; 1×47J; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F91; 2×GOL; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Pyrrolidine fragment 1 bound to endothiapepsin | monomer | 1×TVI; | ||||
| Assess | ||||||
| Endothiapepsin in complex with chiral chlorinated primary amine fragment | monomer | 1×GOL; 1×6LE; 2×ACT; 1×PG4; 1×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 51 | monomer | 3×GOL; 1×DMS; 2×EDO; 1×47Q; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F5N; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragement 305 | monomer | 1×GOL; 1×45J; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG245 complex | monomer | 3×GOL; 1×8KB; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin | monomer | 2×GOL; 1×ACT; 1×DC7; | ||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG283 complex | monomer | 3×GOL; 1×ACT; 1×D8V; | ||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 218 | monomer | 1×4AO; 2×GOL; 1×PEG; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F05; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with ligand 69 | monomer | 1×GOL; 1×L7K; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with 2mM acylhydrazone inhibitor | monomer | 1×1TZ; 4×GOL; 3×DMS; 2×ACT; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F06; 1×GOL; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with fragment 14 | monomer | 1×GOL; 1×PGE; 1×PEG; 1×46V; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapepsin-FRG140 complex | monomer | 3×GOL; 1×DMS; 1×D6Y; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 10% DMSO at 298 K | monomer | 1×U1H; 1×PG5; 2×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 1×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in 10% DMSO at 298 K | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 20% DMSO at 298 K | monomer | 1×PG5; 5×DMS; 1×U1H; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 40% DMSO at 298 K | monomer | 1×PG5; 3×DMS; 1×U1H; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 8% DMSO at 298 K | monomer | 1×U1H; 1×PG5; 2×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 1×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 1×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in 20% DMSO at 298 K | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin apo at 298K | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 1×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 5% DMSO at 298 K | monomer | 1×U1H; 1×PG5; 2×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in 5% DMSO at 298 K | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 1×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 1×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping down struc… | monomer | 2×U1H; 1×PG5; 3×DMS; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 at room-temperature (temperature ramping up structu… | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Crystal structure of Endothiapesin in complex with Xenon | monomer | 1×XE; 3×GOL; | ||||
| Assess | ||||||
| High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide i… | monomer | 1×0EK; | ||||
| Assess | ||||||
| Endothiapepsin in complex with compound TL00150 in 15% DMSO at 298 K | monomer | 2×U1H; 1×PG5; 4×DMS; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with hydrazide fragment | monomer | 2×DMS; 1×FLK; | ||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Automated refinement of diffraction data obtained from an endothiapepsin crystal treated with fragm… | monomer | |||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F63; 1×GOL; | ||||
| Assess | ||||||
| X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION… | monomer | 1×0EM; 2×SO4; | ||||
| Assess | ||||||
| Endothiapepsin in complex with a fragment | monomer | 1×F41; 1×GOL; | ||||
| Assess | ||||||
| ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130,693 (MAS PHE LYS+MTF STA MBA) | monomer | 2×SO4; 1×1Z1; | ||||
| Assess | ||||||
| ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-133,450 (SOT PHE GLY+SCC GCL) | monomer | 1×0QF; 2×SO4; | ||||
| Assess | ||||||
| Endothiapepsin structure obtained at 298K with fragment BTB09871 bound from a dataset collected wit… | monomer | 1×U1E; 18×DMS; 1×1PE; | ||||
| Assess | ||||||
| Endothiapepsin in complex with Gewald reaction-derived inhibitor (6) | monomer | 1×IXY; 1×DMS; | ||||
| Assess | ||||||
| Endothiapepsin structure obtained at 298K after a soaking with fragment AC39729 from a dataset coll… | monomer | 10×DMS; | ||||
| Assess | ||||||
| Type IV native endothiapepsin | monomer | 3×SO4; | ||||
| Assess | ||||||
| The structure of a synthetic pepsin inhibitor complexed with endothiapepsin. | monomer | |||||
| Assess | ||||||
| X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors | monomer | 1×0EO; | ||||
| Assess | ||||||
| A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITI… | monomer | |||||
| Assess | ||||||
| ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME) | monomer | 1×2Z3; | ||||
| Assess | ||||||
| The active site of aspartic proteinases | monomer | 3×SO4; | ||||
| Assess | ||||||
| THE ACTIVE SITE OF ASPARTIC PROTEINASES | monomer | 1×0ZP; | ||||
| Assess | ||||||
| A rational approach to the design of antihypertensives. X-ray studies of complexes between aspartic… | monomer | 1×0HT; | ||||
| Assess | ||||||
| The active site of aspartic proteinases | monomer | 1×0EL; | ||||
| Assess | ||||||
| Endothiapepsin-DB6 complex. | monomer | 3×SO4; | ||||
| Assess | ||||||
| Endothiapepsin complex with renin inhibitor MERCK-KGAA-EMD56133 | monomer | 1×0GQ; | ||||
| Assess | ||||||
| Endothiapepsin complex with inhibitor DB2 | monomer | 1×3AI; | ||||
| Assess | ||||||
| Endothiapepsin complex with renin inhibitor MERCK-KGAA-EMD61395 | monomer | 1×M91; | ||||
| Assess | ||||||
| Endothiapepsin complex with renin inhibitor MERCK-KGAA-EMD59601 | monomer | 1×M90; | ||||
| Assess | ||||||
| Endothiapepsin structure obtained at 298K and 40 mM DMSO from a dataset collected with JUNGFRAU det… | monomer | 8×DMS; 1×PEG; 1×1PE; | ||||
| Assess | ||||||
| THE ACTIVE SITE OF ASPARTIC PROTEINASES | monomer | |||||
| Assess | ||||||
| Endothiapepsin-DB5 complex. | monomer | |||||
| Assess | ||||||
| HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES | monomer | |||||
| Assess | ||||||
| X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES. | monomer | |||||
| Assess | ||||||
| Endothiapepsin structure obtained at 298K after a soaking with fragment JFD03909 from a dataset col… | monomer | 1×DMS; | ||||
| Assess | ||||||
| ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135,040 | monomer | 1×0QS; | ||||
| Assess | ||||||
| X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES | monomer | |||||
| Assess | ||||||
| Neutron diffraction structure of endothiapepsin in complex with a gem- diol inhibitor. | monomer | 1×0QS; | ||||
| Assess | ||||||
| Neutron Laue diffraction structure of endothiapepsin complexed with transition state analogue inhib… | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5hct.1.A | monomer | 0.95 | 1×61P; | 100.00 | ||
| Assess | ||||||